Coherus Oncology (CHRS) Acquisitions (2014)
Coherus Oncology (CHRS) reported Acquisitions of $7 million for FY2023.
Powered by 
Analysis
Coherus Oncology (CHRS) Acquisitions (2014) Analysis & Trends
- Acquisitions has a five-year compound annual growth rate of 87.7% (FY2018 to FY2023).
- The FY2023 figure ranks as the lowest annual Acquisitions since FY2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.54 Bn | 1,195.15 Bn | 20.46 Bn | 887.00 Mn |
| 2 | Johnson & Johnson | 650.21 Bn | 570.07 Bn | 17.30 Bn | -17.15 Bn |
| 3 | AbbVie | 508.24 Bn | 476.24 Bn | 13.12 Bn | 10.59 Bn |
| 4 | Merck | 360.07 Bn | 323.01 Bn | 13.19 Bn | 630.00 Mn |
| 5 | Novartis Ag | 312.26 Bn | 285.49 Bn | - | - |
| 6 | Astrazeneca | 285.31 Bn | 259.20 Bn | 13.26 Bn | - |
| 7 | Amgen | 247.74 Bn | 199.39 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.12 Bn | 182.22 Bn | 6.73 Bn | 19.00 Mn |
| 9 | Pfizer | 166.13 Bn | 113.48 Bn | 12.56 Bn | - |
| 10 | Coherus Oncology | 116.17 Mn | -519.97 Mn | 10.07 Mn | - |
API Access
Coherus Oncology Acquisitions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=acquisitions&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "acquisitions", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=acquisitions&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();